Our study reveals that in NSCLC cells, upregulated PRMT3 promotes IDO1 expression by methylating TFAP2A, thereby activating the tumor’s intrinsic Kyn metabolism and mediating the development of radiation resistance. The gene discussed is IDO1; the disease is neoplasm.